80 related articles for article (PubMed ID: 32266174)
1. Diallyl Trisulfide Inhibits Leptin-induced Oncogenic Signaling in Human Breast Cancer Cells but Fails to Prevent Chemically-induced Luminal-type Cancer in Rats.
Kim SH; Hahm ER; Singh KB; Singh SV
J Cancer Prev; 2020 Mar; 25(1):1-12. PubMed ID: 32266174
[TBL] [Abstract][Full Text] [Related]
2. Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-α-induced Triple Negative Breast Cancer Cells.
Kanga KJW; Kanga LHB; Mendonca P; Soliman KFA; Ferguson DT; Reed SL; Darling-Reed S
Anticancer Res; 2023 Jun; 43(6):2393-2405. PubMed ID: 37247921
[TBL] [Abstract][Full Text] [Related]
3. Diallyl Trisulfide Induces ROS-Mediated Mitotic Arrest and Apoptosis and Inhibits HNSCC Tumor Growth and Cancer Stemness.
Mathan SV; Singh R; Kim SH; Singh SV; Singh RP
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254868
[TBL] [Abstract][Full Text] [Related]
4. Experimental study of inhibitory effects of diallyl trisulfide on the growth of human osteosarcoma Saos-2 cells by downregulating expression of glucose-regulated protein 78.
Zhang Y; Xie WP; Zhang YK; Chen YQ; Wang DL; Li G; Guan DH
Onco Targets Ther; 2018; 11():271-277. PubMed ID: 29386905
[TBL] [Abstract][Full Text] [Related]
5.
Kim SH; Singh KB; Hahm ER; Lokeshwar BL; Singh SV
J Tradit Complement Med; 2020 May; 10(3):188-197. PubMed ID: 32670813
[TBL] [Abstract][Full Text] [Related]
6. Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
Kim SH; Hahm ER; Singh KB; Singh SV
Mol Carcinog; 2020 Oct; 59(10):1116-1128. PubMed ID: 32754922
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
8. The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane.
Hahm ER; Singh KB; Kim SH; Powolny AA; Singh SV
Cancer Prev Res (Phila); 2020 Aug; 13(8):661-672. PubMed ID: 32434809
[TBL] [Abstract][Full Text] [Related]
9. RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.
Hahm ER; Kim SH; Singh KB; Singh SV
Mol Carcinog; 2021 Jan; 60(1):3-14. PubMed ID: 33150660
[TBL] [Abstract][Full Text] [Related]
10. A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer.
Singh KB; Hahm ER; Kim SH; Wendell SG; Singh SV
Oncogene; 2021 Jan; 40(3):592-602. PubMed ID: 33199826
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Targets of Diallyl Trisulfide in Human Breast Cancer Cells Identified by RNA-seq Analysis.
Hahm ER; Kim SH; Mathan SV; Singh RP; Singh SV
J Cancer Prev; 2021 Jun; 26(2):128-136. PubMed ID: 34258251
[TBL] [Abstract][Full Text] [Related]
12. The Garlic Compound, Diallyl Trisulfide, Attenuates Benzo[a]Pyrene-Induced Precancerous Effect through Its Antioxidant Effect, AhR Inhibition, and Increased DNA Repair in Human Breast Epithelial Cells.
Ferguson DT; Taka E; Messeha S; Flores-Rozas H; Reed SL; Redmond BV; Soliman KFA; Kanga KJW; Darling-Reed SF
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38276538
[TBL] [Abstract][Full Text] [Related]
13. The Anticancer Effects of the Garlic Organosulfide Diallyl Trisulfide through the Attenuation of B[a]P-Induced Oxidative Stress, AhR Expression, and DNA Damage in Human Premalignant Breast Epithelial (MCF-10AT1) Cells.
Ferguson DT; Taka E; Tilghman SL; Womble T; Redmond BV; Gedeon S; Flores-Rozas H; Reed SL; Soliman KFA; Kanga KJW; Darling-Reed SF
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255999
[TBL] [Abstract][Full Text] [Related]
14. Updates on the anticancer potential of garlic organosulfur compounds and their nanoformulations: Plant therapeutics in cancer management.
Pandey P; Khan F; Alshammari N; Saeed A; Aqil F; Saeed M
Front Pharmacol; 2023; 14():1154034. PubMed ID: 37021043
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Selective Disruption of Actin Cytoskeleton by Diallyl Trisulfide.
Hahm ER; Mathan SV; Singh RP; Singh SV
J Cancer Prev; 2022 Jun; 27(2):101-111. PubMed ID: 35864856
[TBL] [Abstract][Full Text] [Related]
16. Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer.
Malla R; Marni R; Chakraborty A; Kamal MA
J Pharm Anal; 2022 Apr; 12(2):221-231. PubMed ID: 35582397
[TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide.
Kim SH; Singh SV
Mol Carcinog; 2022 Aug; 61(8):752-763. PubMed ID: 35512572
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Changes by Diallyl Trisulfide Administration in Chemically-induced Mammary Tumors in Rats.
Hahm ER; Singh SV
J Cancer Prev; 2022 Mar; 27(1):22-30. PubMed ID: 35419300
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
